Developing Therapeutics That Teach the Body to Heal Itself
Contributing Author John Vandermosten, Senior Biotechnology Analyst The arc of HIV history has been developing over the last four decades. In the early days there was much we did not know, but as teams of physicians, researchers and patients increased their understanding of the disease, progress was made. Early efforts with repurposed cancer drugs gave way to numerous viral inhibitor combinations. … [Read More]
The Berlin Patient’s success provided optimism that there was a way to permanently disable HIV and eradicate it from an infected person. While a bone marrow transplant is not appropriate for most HIV patients, what we have learned from his experience has provided us clues to find a cure. Removing the door handle HIV uses to gain entry to immune… [Read More]
Contributing Author John Vandermosten, Senior Biotechnology Analyst This is the second installment of our series on the Arc of HIV History which examines the earliest emergence of HIV and the progress that has been made until today. In Part 2 we look at the genesis of the first approved HIV drug and the first cure of HIV in the Berlin Patient…. [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!